Premaitha Share Discussion Threads

[timojelly] 19/6/2017 06:21

We could do with a few £ hitting the bottom line as well

[gooosed] 16/6/2017 12:01

IF Illumina cloud is lifted . . . . . but writ kick off not far away now.

[timojelly] 16/6/2017 11:55

We appear well and truly grounded until Illumina cloud is lifted.

[2vdm] 16/6/2017 07:50

Who cares as long as it works. Be good to get updates on its progress re the roll out

[swiftnick] 16/6/2017 07:43

What a silly name to choose. Sounds like accounting software.

[timojelly] 12/6/2017 08:41

Let's hopefully get Illumina out of the way then the re-rating begins.... All the way to previous 30p+ high

[hjb1] 09/6/2017 17:42

Hotstockrockets

Premaitha (NIPT) has updated investors on its progress in India where it claims now to have representation in 9 of the 15 most populous states with several of the largest nationwide pathology laboratory groups running Yourgene's NIPT workflow in-house.

There are five laboratories with installed NIPT solutions, and an additional two

laboratories are expected to become active later this year. Well goodness gracious me
We are also told that there are currently thirteen Indian laboratory customers sending samples to Yourgene's laboratory in Taiwan for processing and analysis and the expectation is that some of these laboratories in time will establish their NIPT solution in house. Volumes are said to be increasing at 100% per annum. Goodness gracious me again.

What is lacking in this statement is any idea at all of what revenues and margins are. As such, while it all seems very encouraging it is not going to really set the shares racing.

Moreover, the big issue remains not Indians but cowboys - that is to say Illumina and its patent challenge. We expect news on that soon and good news. That is the only thing that will drive a big re-rate. We think it will happen so on that basis the stance - at 9.875p - remains BUY.

[hamidahamida] 07/6/2017 09:34

Tb You bought in over 15p sold out around 9.5p never had the balls to buy back in at all time it was a nice trading opportunity

[hamidahamida] 07/6/2017 09:26

thinkBig panic station you bottled it Go on tell us how much did you lose on this

[timojelly] 07/6/2017 09:09

The clock is ticking... Sooner this is sorted the better, the shareprice will rocket if we win but if Illumina appeals we could drag on at this price for a long time yet.

[gooosed] 05/6/2017 15:52

As of 2 June 2017 :

Page 27

[tsmith2] 05/6/2017 15:42

Have you noticed we never ever get the mention of £xyzs in these bits of news

[the monkster] 05/6/2017 08:09

......and we expect the share price to tank on this news" commented Dr Stephen Little CEO.

[humphries1] 05/6/2017 07:32

05 June 2017

Premaitha Health plc

("Premaitha" or the "Company" or the "Group")

India Business Update

Manchester, UK - 5 June 2017: Premaitha Health plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing, is pleased to provide an update on commercial progress in India.

Yourgene Bioscience ("Yourgene"), acquired by Premaitha in March 2017, is now firmly established as one of India's leading providers in the emerging non-invasive prenatal testing ("NIPT") market, with representation in 9 of the 15 most populous states and several of the largest nationwide pathology laboratory groups running Yourgene's NIPT workflow in-house. There are five laboratories with installed NIPT solutions, and an additional two laboratories are expected to become active later this year. These laboratories have an extensive network of hospitals feeding samples into them across all the regions of the country. In addition, there are currently thirteen Indian laboratory customers sending samples to Yourgene's laboratory in Taiwan for processing and analysis and the expectation is that some of these laboratories in time will establish their NIPT solution in house.

NIPT in India is still in an early phase of development and Yourgene's test volumes are growing at a rate of 100% per annum with coverage across all key metropolitan areas including Mumbai, New Delhi, Bangalore, Hyderabad and Chennai. India has the highest birth rate in the world with over 26 million births per annum, and access to prenatal screening is spreading to the expanding middle class populations living in the cities and regions where screening is available. Yourgene's menu-based test offering allows for testing to be tailored to local ethical and clinical requirements.

Dr Stephen Little, CEO, commented: "With its extremely high birth rate and growing middle class population we expect India, in time, to become a very large market for NIPT and we are well positioned to be one of the principal suppliers to the market in the years to come.

"Premaitha and Yourgene are working closely together to deliver a complementary test offering to suit all sizes of hospital and laboratory customer. We already have a leading presence with growing test volumes from an expanding customer base. I believe our combined product strategy positions us strongly to win significant market share in this country and others with similar health service characteristics."

[thinkbig?] 01/6/2017 15:55

You still here lol.

[hamidahamida] 01/6/2017 12:38

Looks like it's going back to 8p

[hamidahamida] 01/6/2017 12:37

It's getting closer to court case d day and People are scared and selling

[whites123] 01/6/2017 07:43

Edit: Above post meant for "Value growth" forums.
I hold NIPT and inadvertently posted.

[whites123] 01/6/2017 07:42

With the impending election next week, what companies will benefit irrespective of what party wins?

ASH : ASHLEY HOUSE, Most definitely will.

It would appear the likes of ASH are going to be in a win win win situation.

All parties are promising to increase spending on social care.
All parties are pledging to increase funding on social care housing.
All parties are pledging to increase housing stock.
All parties are pledging to promote Modular builds.
All parties are pledging to increase Dr's surgeries and access to bespoke NHS facilities.
All parties are pledging to improve and increase student housing.

Looks like this election could provide the turning point for ASH.
Lets remember that F1 Modular (76% owned by Ashley House)has a target to produce in excess of £4 Million profit within 3 years. That is almost the whole market cap of ASH.!!!!!! Re-rating due? What price? 30p? 40p?
DYOR etc, but a multi bagger should not be stared down.

[ewads] 01/6/2017 07:39

Esperite N.V.
ESPERITE (ESP): L1 Capital subscribes to the se...
Zutphen, The Netherlands, 1 June 2017

As of today, 100% of the EUR 1.0 million initial tranche issued on March 8, 2017 has been converted into shares by European Select Growth Opportunities Fund (the "Investor") as well as the first of the four packed tranches referred to in our press release of yesterday, May 31st 2017.

Today a second tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the "Notes") with a principal amount of EUR 10,000 each, with 250,000 share subscription warrants attached (the "Warrants"), under the financing agreement of up to EUR 13.0 million signed between the Group and the Investor on March 8, 2017 (the "Agreement").

Esperite confirms its appetite for business expansion in the fields of regenerative medicine and for the development of exclusive genetic diagnostic tests.

The Notes and the Warrants issued under the Packed Tranches shall have the same characteristics as those described in the Group's press release dated March 8, 2017.

Frederic Amar, CEO: "This investment allows the Group to unlock its potential and give confidence to the future"

[hjb1] 26/5/2017 09:19

also forget about the stupid Esperite claim too, won't happen imo, just a smokescreen for their internal probs.

[timojelly] 26/5/2017 08:01

Clearly Thermofisher not concerned about any writ.

[2vdm] 26/5/2017 07:50

Yet another piece in the jigsaw. Good news.

[thinkbig?] 19/5/2017 17:24

It does look like seller Is here again can not hold any gains. So the only reason for that is More sellers than buyers. But someone is dumping again. Needs to find a new big buyer of the stock or we are stuck here for a long while.